Loading clinical trials...
Loading clinical trials...
The primary aim of this study is to investigate the effect of 40 mg dose of rosuvastatin on carotid plaque inflammation measured with MRI and PET scanning, to evaluate whether these techniques are pro...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT01399385 · Healthy, Obesity, and more
NCT00353782 · Hypercholesterolemia, Atherosclerosis
NCT07241390 · Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
NCT01143454 · Metabolic Disease, Obesity, and more
NCT05316311 · Intracranial Atherosclerosis
Research Site
Uppsala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions